Brief: Indaptus Therapeutics Says Decoy20 Demonstrated a Broad Immune Response of More than 50 Cytokines and Chemokines in Patients Following a Single Dose
06/11/2023 14:14
Nov 6 (Reuters) - Indaptus Therapeutics Inc INDP.O :
* INDAPTUS THERAPEUTICS’ DECOY20 DEMONSTRATED A BROAD IMMUNE
RESPONSE OF MORE THAN FIFTY CYTOKINES AND CHEMOKINES IN PATIENTS
FOLLOWING A SINGLE DOSE IN FIRST COHORT OF ONGOING PHASE 1 STUDY
Source text for Eikon: ID:nGNX5c5ypw
Further company coverage: INDP.O
((Reuters.Briefs@thomsonreuters.com;))